July 15th 2025
Northway Biotech will develop and scale production of AATec’s ATL-105 for the treatment of non-CF bronchiectasis.
Sai Life Sciences’ Screening Capabilities Enhanced with Expanded Cellular Analysis Platforms
September 28th 2020Following a recent expansion at its Cambridge, MA, facility, the company now houses a new suite of cellular analysis platforms that enhance its exploratory capabilities into oncology, neuroscience, and rare diseases.